What we're reading, January 13, 2017: more states consider contraception laws with Affordable Care Act (ACA) in peril; GOP will speed up timeline to replace ACA; Tom Price will sell his stocks to avoid conflicts.
When the Affordable Care Act (ACA) is repealed by Republicans in Congress, millions of women will lose access to free birth control. According to Reuters, an increasing number of states are looking to join the ranks of California, Maryland, Vermont, and Illinois, which added the ACA’s contraception mandate into state law. Democrats in Colorado, Massachusetts, Minnesota, and New York are considering similar measures since President Barack Obama’s healthcare law, and the contraception mandate, are in peril.
Meanwhile, the repeal of the ACA is undergoing some timeline changes. Initially, GOP leadership were considering repealing the law immediately, but delaying the effects for 2 or 3 years while a replacement was hammered out. After the president-elect said he wanted repeal and replace to take place almost simultaneously, Republicans in Congress have changed their tune, reported The Wall Street Journal. House Speaker Paul Ryan, R-Wisconsin, is now saying that the House will have replacement legislation alongside the repeal. With no replacement legislation yet announced, Republicans will have a tight deadline to meet.
After calls for an ethics investigation from some Democrats that Representative Tom Price, R-Georgia, the president-elect’s pick to run HHS, will sell of his stock holdings. Price currently holds stock in more than 40 companies, but he will divest himself of that stock if the Senate confirms him, according to The New York Times. Democrats had raised concerns that Price may have add access to insider information. In addition, Price will resign from his position with the American Medical Association.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More